The Clay Travis Buck Sexton Show
@clayandbuck·130K subscribers·6.7K videos
RFK Jr. Explains Why FDA Approves Drugs But NOT Supplements & Peptides
Posted
April 7, 2026
Views
817
Likes
24
Engagement
2.94%
April 7, 2026
817
24
2.94%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
0:59Now PlayingRFK Jr. joins Clay & Buck and nails the key difference: FDA requires rigorous pre-market approval and clinical trials for drugs that treat diseases (like heart meds or weight-loss drugs). But dietary supplements and many peptides operate under the 1994 DSHEA law — no mandatory FDA review before hitting the market. Manufacturers handle safety and labeling, with FDA stepping in only if problems arise. Is this framework too loose… or does it protect innovation and consumer choice? Full interview on The Clay Travis & Buck Sexton Show. What do you think — should peptides get easier access or stricter rules? Comment below! #RFKJr #FDA #Supplements #Peptides #MakeAmericaHealthyAgain #ClayAndBuck
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
